Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Vulvar acne, also known as "vulvar Fordyce adenitis", is a condition causing painful bumps on the labia, and it's not always effectively treated with common acne medications, but isotretinoin has shown promise.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Intralesional steroids can help regrow hair in some alopecia areata patients but have side effects.

Upadacitinib effectively treats psoriasis and lichen planus together.

Triamcinolone acetonide mesotherapy may be effective for treating patchy hair loss in alopecia areata.

Oral baricitinib is effective and safe for treating alopecia areata.

Tretinoin may be effective for treating Fox-Fordyce disease.

The session covered updates on skin treatments, including radiotherapy, imiquimod, acitretin, JAK inhibitors, and strategies for managing rosacea and preventing surgical infections.

Atorvastatin is less effective for women with Hashimoto's thyroiditis.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Using tazarotene with GliSODin improves facial skin more than tazarotene alone.

A patient with granuloma annulare experienced both isotopic and isomorphic responses, with skin lesions responding to steroids but relapsing after stopping treatment.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Infliximab may cause hair loss in Crohn's disease patients.

Intralesional triamcinolone acetonide is effective and safe for treating early to mid-stage traction alopecia.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

The new micelle formulation delivers acne treatment more effectively and safely than current gels.

The combination therapy significantly improved Riehl’s melanosis in patients without serious side effects.

Intramuscular cyproterone acetate effectively treats hirsutism and improves skin conditions in women with hyperandrogenism.